These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 8551900

  • 1. Abnormal lipid profiles on fibrate derivatives.
    McLeod AJ, Warren RJ, Armitage M.
    Lancet; 1996 Jan 27; 347(8996):261. PubMed ID: 8551900
    [No Abstract] [Full Text] [Related]

  • 2. Lipid profiles on fibric-acid derivatives.
    Capps NE.
    Lancet; 1994 Sep 03; 344(8923):684-5. PubMed ID: 7915370
    [No Abstract] [Full Text] [Related]

  • 3. Ciprofibrate and lipid profile.
    Chandler HA, Batchelor AJ.
    Lancet; 1994 Jul 09; 344(8915):128-9. PubMed ID: 7912363
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidism.
    Liberopoulos E, Miltiadous G, Elisaf M.
    Diabetes Obes Metab; 2001 Apr 09; 3(2):97-8. PubMed ID: 11298731
    [Abstract] [Full Text] [Related]

  • 6. [The treatment of chronic ischemic heart disease: the potentials for hypolipidemic correction using current drugs].
    Tashchuk VK, Makoviĭchuk IO, Bilets'kyĭ SV, Hrechko SI, Polishchuk OIu, Turubarova NA.
    Lik Sprava; 1998 Apr 09; (5):101-3. PubMed ID: 9793321
    [Abstract] [Full Text] [Related]

  • 7. Comparative efficacy and safety of ciprofibrate and sustained-release bezafibrate in patients with type II hyperlipidaemia.
    Betteridge DJ, O'Bryan-Tear CG.
    Postgrad Med J; 1996 Dec 09; 72(854):739-43. PubMed ID: 9015467
    [Abstract] [Full Text] [Related]

  • 8. Differential associations of statin and fibrate treatment with carotid arterial remodeling.
    Chironi G, Simon A, Gariepy J, Balice M, Del-Pino M, Levenson J.
    Am J Hypertens; 2005 Nov 09; 18(11):1476-81. PubMed ID: 16280285
    [Abstract] [Full Text] [Related]

  • 9. Biliary lipids, lithogenic index and biliary drug concentrations during etofibrate and bezafibrate treatment.
    Raedsch R, Plachky J, Wolf N, Simonis G.
    Eur J Drug Metab Pharmacokinet; 1995 Nov 09; 20(2):113-8. PubMed ID: 8582435
    [Abstract] [Full Text] [Related]

  • 10. Fibrate-induced increase in blood urea and creatinine.
    Lipscombe J, Bargman JM.
    Nephrol Dial Transplant; 2001 Jul 09; 16(7):1515. PubMed ID: 11427661
    [No Abstract] [Full Text] [Related]

  • 11. [The action of a fibric acid derivative on lipid metabolism].
    Filip M, Păduraru I, Nechifor M, Dănilă GH, Popovici I, Filip FM, Poşircă F.
    Rev Med Chir Soc Med Nat Iasi; 1989 Jul 09; 93(3):573-6. PubMed ID: 2636755
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of various fibrates on serum alkaline phosphatase activity.
    Ganotakis E, Tsimihodimos V, Bairaktari E, Rizos E, Athyros V, Seferiades C, Elisaf M.
    Atherosclerosis; 2002 Nov 09; 165(1):187-8. PubMed ID: 12208487
    [No Abstract] [Full Text] [Related]

  • 14. Fibrate monotherapy and profound hypoalphalipoproteinaemia.
    Olukoga AO, Crowley VE, Stewart MF, Weinkove O.
    Postgrad Med J; 1996 Mar 09; 72(845):189. PubMed ID: 8731722
    [No Abstract] [Full Text] [Related]

  • 15. Drug interactions with fibric acids.
    Lozada A, Dujovne CA.
    Pharmacol Ther; 1994 Aug 09; 63(2):163-76. PubMed ID: 7809177
    [Abstract] [Full Text] [Related]

  • 16. Fibrates, dyslipoproteinaemia and cardiovascular disease.
    Watts GF, Dimmitt SB.
    Curr Opin Lipidol; 1999 Dec 09; 10(6):561-74. PubMed ID: 10680050
    [Abstract] [Full Text] [Related]

  • 17. [Bezafibrate and delayed action etofibrate in hyperlipidemia].
    Lang PD, Vollmar J.
    Dtsch Med Wochenschr; 1983 Feb 25; 108(8):302-5. PubMed ID: 6825604
    [No Abstract] [Full Text] [Related]

  • 18. Effects of fibric acid derivatives on biliary lipid composition.
    Palmer RH.
    Am J Med; 1987 Nov 27; 83(5B):37-43. PubMed ID: 3318452
    [Abstract] [Full Text] [Related]

  • 19. Fibrates and HDL cholesterol.
    Murphy MJ, Packard CJ, O'Reilly DS.
    Ann Clin Biochem; 1997 Jan 27; 34 ( Pt 1)():114. PubMed ID: 9022900
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of dyslipidaemias in patients with established vascular disease: a revival of the fibrates.
    Milionis HJ, Elisaf MS, Mikhailidis DP.
    Curr Med Res Opin; 2000 Jan 27; 16(1):21-32. PubMed ID: 16422031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.